Category Archives: Institutional and special event

Inserm: sport and health, a winning combination

Illustration sport et santé bar Ambre Rolland et Inserm : jeune femme portant des haltères

Over the last few years, Inserm has become a world leader in the field of sport and health research. Here we provide an overview of recent work at the Institute to mark the Sport Unlimitech festival for sport and innovation, which is being held in Lyon from September 19-21, 2019, in partnership with Inserm.

Also posted in Press releases | Comments closed

Alain Eychène, head of Research and Innovation at the French National Cancer Institute and head of the Aviesan Multi-Organization Institute for Cancer

Inserm Research Director Alain Eychène is taking the helm at the French National Cancer Institute’s Research and Innovation division. In this new role, he will also head the Aviesan Multi-Organization Institute (ITMO) for cancer and will manage Inserm’s Cancer institute.

Also posted in Press releases | Comments closed

Art and Science program: Inserm at the Rencontres d’Arles and Avignon Festival

Inserm is reaching out to a new audience among the general public this summer by taking part in two events that bring together art and science in a mutually enriching way: the 8th Recherche de l’art (Art of Research) exhibition at the Rencontres d’Arles, in partnership with the École nationale supérieure de la photographie, and the 10th edition of the binôme program at the Avignon Festival, led by the Les sens des mots theater company.

Also posted in Press releases | Tagged | Comments closed

Lancement de SCAI : un centre de l’intelligence artificielle au coeur de Sorbonne Université

Lancement de SCAI : un centre de l’intelligence artificielle au coeur de Sorbonne Université

Also posted in Press releases | Tagged | Comments closed

Gilles Bloch, Inserm Chairman and Chief Executive Officer, takes office

Appointed by the French Council of Ministers on November 26, 2018, Gilles Bloch took up his post as Chairman and Chief Executive Officer of Inserm on January 2, 2019.

Also posted in Press releases | Comments closed

The 2018 Inserm Prizes: Spotlight on Health Research

This year’s Inserm Prize ceremony will take place on Tuesday December 11, 2018, at the Collège de France in celebration of nine researchers and engineers whose achievements have helped raise the level of scientific excellence at the Institute, in the service of science for health. “By honoring its talents, Inserm wishes to showcase the diversity and richness of the biomedical research professions, and the creativity and passion of the women and men who drive them on a daily basis”, states Claire Giry, Inserm Director General and acting President. The 2018 Inserm Grand Prize will go to Alain Tedgui for his research on identifying the role of the immune system in atherosclerosis. Two clinical trials directly resulting from his research are currently ongoing.

Also posted in Press releases | Comments closed

Gilles Bloch appointed Chairman and Chief Executive Officer of Inserm

Gilles Bloch has been appointed Chairman and Chief Executive Officer of the French National Institute of Health and Medical Research (Inserm) by the Council of Ministers.

Also posted in Press releases | Tagged | Comments closed

L’Inserm lance « Canal Détox », un outil d’information scientifique pour toutes et tous

Pour combattre la désinformation et rendre la parole à la science, l’Inserm lance sa nouvelle série destinée à valoriser la parole scientifique: Canal Détox,

Also posted in Press releases | Tagged | Comments closed

The FOReSIGHT project has been awarded University Hospital Institute status, reflecting the success of a long-term commitment by Inserm, Sorbonne Université, Quinze-Vingts National Ophthalmology Hospital and the Seeing and Hearing Foundation.

Le succès d’un engagement sur le long terme de l’Inserm, de Sorbonne Université, du Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts et de la Fondation Voir et Entendre: ces partenaires fondateurs de l’IHU FOReSIGHT s’engagent dans un projet d’exception visant à relever les défis des maladies de la vision. Centré autour de l’Institut de la Vision dirigé par le Pr José-Alain Sahel, le projet intègre une recherche fondamentale et clinique d’excellence pour améliorer les connaissances et les traitements des malades atteints de DMLA, glaucomes, rétinopathies diabétiques et dégénérescences d’origine génétique. L’IHU, au-delà de la compréhension de ces pathologies est lui centré sur la restauration de la vision.

Also posted in Press releases | Tagged | Comments closed

“Together against rheumatism day” returns for a 5th edition in October 2018

L’Inserm/Aviesan, la Société Française de Rhumatologie, la Fondation Arthritis et 17 associations partenaires s’associent pour la 5ème journée « Ensemble contre les rhumatismes » le 12 octobre 2018, sous le Haut patronage de Monsieur Emmanuel MACRON, Président de la République.
Cette journée s’inscrit dans un double objectif : répondre au besoin de communication entre les patients, les médecins et les chercheurs et faire “du buzz” autour de la nécessité de soutenir la recherche sur les rhumatismes et les maladies musculo-squelettiques en France.

Also posted in Press releases | Tagged | Comments closed
fermer
fermer
RSS Youtube